{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:38:30Z","timestamp":1792521510821,"version":"4.5.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jchf.2019.09.002","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T13:57:19Z","timestamp":1573048639000},"page":"35-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["HFpEF Is the Substrate for Stroke in Obesity and Diabetes Independent of\u00a0Atrial Fibrillation"],"prefix":"10.1016","volume":"8","author":[{"given":"Milton","family":"Packer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2019.09.002_bib1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fendo.2017.00160","article-title":"Targeting obesity and diabetes to treat heart failure with preserved ejection fraction","volume":"8","author":"Altara","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jchf.2019.09.002_bib2","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1161\/01.STR.25.12.2370","article-title":"Body mass index and thromboembolic stroke in nonsmoking men in older middle age. The Honolulu Heart Program","volume":"25","author":"Abbott","year":"1994","journal-title":"Stroke"},{"key":"10.1016\/j.jchf.2019.09.002_bib3","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.mayocp.2016.10.008","article-title":"CHA2DS2-VASc score: a predictor of thromboembolic events and mortality in patients with an implantable monitoring device without atrial fibrillation","volume":"92","author":"Parsons","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jchf.2019.09.002_bib4","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCULATIONAHA.110.009035","article-title":"Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study","volume":"123","author":"Huxley","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2019.09.002_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/heartjnl-2011-300503","article-title":"Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study","volume":"98","author":"Huxley","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.jchf.2019.09.002_bib6","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1161\/STROKEAHA.111.614099","article-title":"Measures of abdominal adiposity and the risk of stroke: the MOnica Risk, Genetics, Archiving and Monograph (MORGAM) study","volume":"42","author":"Bodenant","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.jchf.2019.09.002_bib7","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.amjmed.2012.11.024","article-title":"Body mass index and adverse events in patients with incident atrial fibrillation","volume":"126","author":"Overvad","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.jchf.2019.09.002_bib8","first-page":"742","article-title":"Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials","volume":"38","author":"Abdul-Rahim","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2019.09.002_bib9","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrcardio.2016.106","article-title":"Stroke risk assessment in atrial fibrillation: risk factors and markers of atrial myopathy","volume":"13","author":"Calenda","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jchf.2019.09.002_bib10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/ejhf.1399","article-title":"Impaired left atrial strain predicts abnormal exercise haemodynamics in heart failure with preserved ejection fraction","volume":"21","author":"Telles","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2019.09.002_bib11","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.jacc.2018.03.509","article-title":"Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium","volume":"71","author":"Packer","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2019.09.002_bib12","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/ejhf.1294","article-title":"The epicardial adipose inflammatory triad: coronary atherosclerosis, atrial fibrillation, and heart failure with a preserved ejection fraction","volume":"20","author":"Packer","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2019.09.002_bib13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","article-title":"Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction","volume":"136","author":"Obokata","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2019.09.002_bib14","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.jacep.2018.08.014","article-title":"Electroanatomical remodeling of the atria in obesity: impact of adjacent epicardial fat","volume":"4","author":"Mahajan","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jchf.2019.09.002_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/CIRCHEARTFAILURE.112.972828","article-title":"Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction","volume":"6","author":"Ho","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2019.09.002_bib16","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/eurheartj\/eht066","article-title":"Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND","volume":"34","author":"Brouwers","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2019.09.002_bib17","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/CIRCULATIONAHA.113.001475","article-title":"Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study","volume":"128","author":"Zakeri","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2019.09.002_bib18","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jchf.2017.05.001","article-title":"Atrial fibrillation in heart failure with preserved, mid-range, and reduced ejection fraction","volume":"5","author":"Sartipy","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2019.09.002_bib19","first-page":"546","article-title":"Relationship between exercise induced elevation of left ventricular filling pressure and exercise intolerance in patients with atrial fibrillation","volume":"13","author":"Chen","year":"2016","journal-title":"J\u00a0Geriatr Cardiol"},{"key":"10.1016\/j.jchf.2019.09.002_bib20","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.cardfail.2017.04.002","article-title":"Prevalence and predictors of early heart failure with preserved ejection fraction in patients with paroxysmal atrial fibrillation","volume":"23","author":"Meluzin","year":"2017","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jchf.2019.09.002_bib21","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/CIRCULATIONAHA.117.030093","article-title":"High prevalence of occult heart failure with preserved ejection fraction among patients with atrial fibrillation and dyspnea","volume":"137","author":"Reddy","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2019.09.002_bib22","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/CIRCULATIONAHA.109.882241","article-title":"Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community","volume":"121","author":"Schnabel","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2019.09.002_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177684","article-title":"Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: a report from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)","volume":"12","author":"AlBadri","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jchf.2019.09.002_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201836","article-title":"High-sensitivity C-reactive protein in heart failure with preserved ejection fraction","volume":"13","author":"DuBrock","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jchf.2019.09.002_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099495","article-title":"Circulating levels of tumor necrosis factor-alpha receptor 2 are increased in heart failure with preserved ejection fraction relative to heart failure with reduced ejection fraction: evidence for a divergence in pathophysiology","volume":"9","author":"Putko","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jchf.2019.09.002_bib26","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.2147\/TCRM.S94955","article-title":"Association of epicardial adipose tissue thickness and inflammation parameters with CHA2DS2-VASASc score in patients with nonvalvular atrial fibrillation","volume":"11","author":"Akdag","year":"2015","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.jchf.2019.09.002_bib27","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002874","article-title":"Association of increased epicardial adipose tissue thickness with adverse cardiovascular outcomes in patients with atrial fibrillation","volume":"95","author":"Chu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jchf.2019.09.002_bib28","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.jcmg.2016.12.005","article-title":"Epicardial fat volume and the risk of atrial fibrillation in the general population free of cardiovascular disease","volume":"10","author":"Bos","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jchf.2019.09.002_bib29","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1253\/circj.CJ-18-0021","article-title":"Effect of the epicedial adipose tissue volume on the prevalence of paroxysmal and persistent atrial fibrillation","volume":"82","author":"Oba","year":"2018","journal-title":"Circ J"},{"key":"10.1016\/j.jchf.2019.09.002_bib30","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/ejhf.1283","article-title":"Epicardial fat in heart failure patients with mid-range and preserved ejection fraction","volume":"20","author":"van Woerden","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2019.09.002_bib31","article-title":"Differential effects of bariatric surgery versus exercise on excessive visceral fat deposits","volume":"95","author":"Wu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jchf.2019.09.002_bib32","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.ahj.2015.07.026","article-title":"Effect of an intensive lifestyle intervention on atrial fibrillation risk in individuals with type 2 diabetes: the Look AHEAD randomized trial","volume":"170","author":"Alonso","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2019.09.002_bib33","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/obr.12270","article-title":"Comparison of reducing epicardial fat by exercise, diet or bariatric surgery weight loss strategies: a systematic review and meta-analysis","volume":"16","author":"Rabkin","year":"2015","journal-title":"Obes Rev"},{"key":"10.1016\/j.jchf.2019.09.002_bib34","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/jama.2013.280521","article-title":"Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial","volume":"310","author":"Abed","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2019.09.002_bib35","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY)","volume":"65","author":"Pathak","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2019.09.002_bib36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.2011.1914","article-title":"Bariatric surgery and long-term cardiovascular events","volume":"307","author":"Sj\u00f6str\u00f6m","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2019.09.002_bib37","doi-asserted-by":"crossref","first-page":"28430","DOI":"10.1074\/jbc.M103382200","article-title":"Insulin-induced adipocyte differentiation. Activation of CREB rescues adipogenesis from the arrest caused by inhibition of prenylation","volume":"276","author":"Klemm","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jchf.2019.09.002_bib38","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jacc.2016.10.069","article-title":"Insulin-requiring versus noninsulin-requiring diabetes and thromboembolic risk in patients with atrial fibrillation: PREFER in AF","volume":"69","author":"Patti","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2019.09.002_bib39","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijcard.2018.06.106","article-title":"Statin therapy modulates thickness and inflammatory profile of human epicardial adipose tissue","volume":"274","author":"Parisi","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jchf.2019.09.002_bib40","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.4238\/2013.September.10.5","article-title":"Effect of atorvastatin on left atrial function of patients with paroxysmal atrial fibrillation","volume":"12","author":"Li","year":"2013","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.jchf.2019.09.002_bib41","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijcard.2007.07.137","article-title":"Statin use and development of atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials and observational studies","volume":"126","author":"Liu","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jchf.2019.09.002_bib42","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.amjcard.2017.04.011","article-title":"Effect of addition of a statin to warfarin on thromboembolic events in Japanese patients with nonvalvular atrial fibrillation and diabetes mellitus","volume":"120","author":"Kumagai","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2019.09.002_bib43","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1530\/JME-17-0066","article-title":"A\u00a0role for PFKFB3\/iPFK2 in metformin suppression of adipocyte inflammatory responses","volume":"59","author":"Qi","year":"2017","journal-title":"J\u00a0Mol Endocrinol"},{"key":"10.1016\/j.jchf.2019.09.002_bib44","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12933-014-0123-x","article-title":"Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in\u00a0vitro studies","volume":"13","author":"Chang","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jchf.2019.09.002_bib45","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.09.001","article-title":"Metformin-inclusive therapy reduces the risk of stroke in patients with diabetes: a 4-year follow-up study","volume":"23","author":"Cheng","year":"2014","journal-title":"J\u00a0Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jchf.2019.09.002_bib46","article-title":"Influence of left atrial function on exercise capacity and left ventricular function in patients with heart failure and preserved ejection fraction","volume":"10","author":"von Roeder","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jchf.2019.09.002_bib47","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1161\/CIRCHEARTFAILURE.114.001667","article-title":"Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction","volume":"8","author":"Melenovsky","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2019.09.002_bib48","doi-asserted-by":"crossref","DOI":"10.1177\/2042018819861593","article-title":"Differential left ventricular and left atrial remodelling in heart failure with preserved ejection fraction patients with and without diabetes","volume":"10","author":"Gulsin","year":"2019","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.jchf.2019.09.002_bib49","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1001\/jama.292.20.2471","article-title":"Obesity and the risk of new-onset atrial fibrillation","volume":"292","author":"Wang","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2019.09.002_bib50","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/ejhf.959","article-title":"Atrial fibrillation modifies the association between pulmonary artery wedge pressure and left ventricular end-diastolic pressure","volume":"19","author":"Dickinson","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2019.09.002_bib51","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.1464","article-title":"Left atrial strain and compliance in the diagnostic evaluation of heart failure with preserved ejection fraction","volume":"21","author":"Reddy","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2019.09.002_bib52","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/ejhf.957","article-title":"Echocardiographic estimation of left ventricular and pulmonary pressures in patients with heart failure and preserved ejection fraction: a study utilizing simultaneous echocardiography and invasive measurements","volume":"19","author":"Hummel","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2019.09.002_bib53","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00392-018-1399-8","article-title":"Left atrial strain improves estimation of filling pressures in heart failure: a simultaneous echocardiographic and invasive haemodynamic study","volume":"108","author":"Lundberg","year":"2019","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jchf.2019.09.002_bib54","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.003754","article-title":"Prognostic utility and clinical significance of cardiac mechanics in heart failure with preserved ejection fraction: importance of left atrial strain","volume":"9","author":"Freed","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jchf.2019.09.002_bib55","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/CIRCHEARTFAILURE.114.001523","article-title":"History of atrial fibrillation as a risk factor in patients with heart failure and preserved ejection fraction","volume":"7","author":"Oluleye","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2019.09.002_bib56","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.amjcard.2010.09.042","article-title":"Effect of elevated left ventricular diastolic filling pressure on the frequency of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation","volume":"107","author":"Iwakura","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2019.09.002_bib57","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s10554-016-0916-y","article-title":"Derivation and validation of E\/e' ratio as a parameter in the evaluation of left atrial appendage thrombus formation in patients with nonvalvular atrial fibrillation","volume":"32","author":"Garcia-Sayan","year":"2016","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.jchf.2019.09.002_bib58","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jns.2008.04.006","article-title":"Tissue Doppler index, E\/E', and ischemic stroke in patients with atrial fibrillation and preserved left ventricular ejection fraction","volume":"271","author":"Lee","year":"2008","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.jchf.2019.09.002_bib59","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0735-1097(93)90688-W","article-title":"Hematologic correlates of left atrial spontaneous echo contrast and thromboembolism in nonvalvular atrial fibrillation","volume":"21","author":"Black","year":"1993","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2019.09.002_bib60","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0894-7317(14)80480-X","article-title":"Significant mitral regurgitation is protective against left atrial spontaneous echo contrast and thrombus as assessed by trans-esophageal echocardiography","volume":"6","author":"Movsowitz","year":"1993","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jchf.2019.09.002_bib61","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1161\/STROKEAHA.115.011273","article-title":"Left atrial appendage function and stroke risk","volume":"46","author":"Yaghi","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.jchf.2019.09.002_bib62","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/jce.12199","article-title":"Association of atrial fibrosis quantified using LGE-MRI with atrial appendage thrombus and spontaneous contrast on transesophageal echocardiography in patients with atrial fibrillation","volume":"24","author":"Akoum","year":"2013","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jchf.2019.09.002_bib63","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/CIRCEP.109.849638","article-title":"The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study","volume":"2","author":"Glotzer","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jchf.2019.09.002_bib64","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2019.09.002_bib65","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/STROKEAHA.109.571455","article-title":"Incidence of newly detected atrial arrhythmias via implantable devices in patients with a history of thromboembolic events","volume":"41","author":"Ziegler","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.jchf.2019.09.002_bib66","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","article-title":"Cryptogenic stroke and underlying atrial fibrillation","volume":"370","author":"Sanna","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2019.09.002_bib67","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/CIRCULATIONAHA.113.007825","article-title":"Temporal relationship between subclinical atrial fibrillation and embolic events","volume":"129","author":"Brambatti","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2019.09.002_bib68","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1161\/CIRCULATIONAHA.115.020252","article-title":"Clinical implications of brief device-detected atrial tachyarrhythmias in a cardiac rhythm management device population: results from the registry of atrial tachycardia and atrial fibrillation episodes","volume":"134","author":"Swiryn","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2019.09.002_bib69","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/eurheartj\/ehv115","article-title":"Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices","volume":"36","author":"Martin","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2019.09.002_bib70","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/ejhf.812","article-title":"High prevalence of subclinical cerebral infarction in patients with heart failure with preserved ejection fraction","volume":"19","author":"Cogswell","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2019.09.002_bib71","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jcmg.2012.10.019","article-title":"LA volumes and reservoir function are associated with subclinical cerebrovascular disease: the CABL (Cardiovascular Abnormalities and Brain Lesions) study","volume":"6","author":"Russo","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jchf.2019.09.002_bib72","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jacc.2010.09.049","article-title":"Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation","volume":"57","author":"Daccarett","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2019.09.002_bib73","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/j.jacc.2015.03.557","article-title":"Fibrotic atrial cardiomyopathy, atrial fibrillation, and thromboembolism: mechanistic links and clinical inferences","volume":"65","author":"Hirsh","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2019.09.002_bib74","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/jama.2015.10725","article-title":"Assessment of the CHA2DS2-VASc score in predicting ischemic stroke, thromboembolism, and death in patients with heart failure with and without atrial fibrillation","volume":"314","author":"Melgaard","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2019.09.002_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2016.02.004","article-title":"Diabetes mellitus and risk of ischemic stroke in patients with heart failure and no atrial fibrillation","volume":"209","author":"Melgaard","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jchf.2019.09.002_bib76","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000476030","article-title":"A\u00a0clinical score for predicting atrial fibrillation in patients with cryptogenic stroke or transient ischemic attack","volume":"138","author":"Kwong","year":"2017","journal-title":"Cardiology"},{"key":"10.1016\/j.jchf.2019.09.002_bib77","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/jce.12652","article-title":"Blood pressure and atrial fibrillation: a combined AF-CHF and AFFIRM analysis","volume":"26","author":"Tremblay-Gravel","year":"2015","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jchf.2019.09.002_bib78","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.hrthm.2011.11.013","article-title":"Long-term effects of catheter ablation for lone atrial fibrillation: progressive atrial electroanatomic substrate remodeling despite successful ablation","volume":"9","author":"Teh","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jchf.2019.09.002_bib79","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/eurheartj\/ehw087","article-title":"Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries","volume":"37","author":"Friberg","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2019.09.002_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186856","article-title":"The effects of rhythm control strategies versus rate control strategies for atrial fibrillation and atrial flutter: a systematic review with meta-analysis and trial sequential analysis","volume":"12","author":"Sethi","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jchf.2019.09.002_bib81","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1093\/eurheartj\/ehi306","article-title":"Rate-control vs. rhythm-control in patients with atrial fibrillation: a meta-analysis","volume":"26","author":"Testa","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2019.09.002_bib82","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177919307371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177919307371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:52:14Z","timestamp":1761972734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177919307371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S2213177919307371"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2019.09.002","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HFpEF Is the Substrate for Stroke in Obesity and Diabetes Independent of\u00a0Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2019.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}